Skip to Main Content

Mariya Rozenblit, MD

Assistant Professor of Medicine (Medical Oncology)
DownloadHi-Res Photo

About

Titles

Assistant Professor of Medicine (Medical Oncology)

Biography

Dr. Mariya Rozenblit is an Assistant Professor of Medicine in the section of Medical Oncology and cares for patients with a clinical focus on breast cancer. She completed her Fellowship in Medical Oncology-Hematology at Yale, Residency in Internal Medicine at NYU, and received her medical degree from Icahn School of Medicine. She is involved in educating medical students, residents, and fellows at Yale. Outside of the clinic, her focus is translational research with an interest in biomarker driven trial development in breast cancer.

In 2020, she was the recipient of the ASCO Conquer Cancer Foundation Young Investigator Award for her project, “Using single nucleotide variants of high functional importance to predict the risk of developing breast cancer in young women with high risk family history.” This award is for promising investigators to encourage and promote quality research in clinical oncology. In 2022, she was the recipient of the Susan G. Komen Career Catalyst Research Grant for her project, "Curing de novo oligometastatic HER2+ breast cancer". This grant is to foster promising breast cancer researchers by providing support for up to three years.

Appointments

Education & Training

Internal Medicine Resident
NYU Langone Medical Center (2018)
MD
Icahn School of Medicine at Mount Sinai (2015)
BA
Columbia University, Biology (2009)

Research

Research at a Glance

Yale Co-Authors

Frequent collaborators of Mariya Rozenblit's published research.

Publications

2023

2022

Clinical Trials

Current Trials

Academic Achievements & Community Involvement

  • honor

    Susan G. Komen Career Catalyst Award

  • honor

    ASCO Conquer Cancer Foundation Young Investigator Award

Clinical Care

Overview

Mariya Rozenblit, MD, is a medical oncologist who specializes in treating patients with different types of breast cancer, from ductal carcinoma in situ (DCIS), the most common type of breast cancer, to metastatic breast cancer, or stage IV breast cancer.

Dr. Rozenblit research focuses on biomarker-driven trial development in breast cancer. These types of clinical trials allow researchers to investigate how patients (including those with different cancer mutations) respond to available medications. For example, Dr. Rozenblit co-authored a study that found patients younger than 40 with advanced breast cancer often suffer a worse prognosis and more severe symptoms than older patients.

She has received the American Society of Clinical Oncology’s Conquer Cancer Foundation’s Young Investigator Award and the Susan G. Komen Cancer Catalyst Research Grant. Dr. Rozenblit is an assistant professor of medicine (medical oncology) at Yale School of Medicine.

Clinical Specialties

Medical Oncology

Fact Sheets

Board Certifications

  • Hematology (Internal Medicine)

    Certification Organization
    AB of Internal Medicine
    Original Certification Date
    2022
  • Internal Medicine

    Certification Organization
    AB of Internal Medicine
    Original Certification Date
    2018

Yale Medicine News

Get In Touch

Contacts

Appointment Number

Administrative Support

Locations

  • Patient Care Locations

    Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.